TY - JOUR T1 - Reply: Advantages and Limits of Targeted Radionuclide Therapy with Somatostatin Antagonists JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 547 LP - 548 DO - 10.2967/jnumed.117.203703 VL - 59 IS - 3 AU - Guillaume P. Nicolas AU - Damian Wild AU - Melpomeni Fani Y1 - 2018/03/01 UR - http://jnm.snmjournals.org/content/59/3/547.abstract N2 - ER -